PMID: 15232243Jul 3, 2004Paper

Emergency department use by infants less than 14 days of age

Pediatric Emergency Care
T J T KennedyK A Jangaard

Abstract

To determine the factors associated with nonacute presentation to the emergency department (ED) by infants less than 14 days of age. A prospective survey was conducted in the pediatric ED of a teaching hospital providing voluntary in-home follow-up for families discharged within 48 hours of delivery. Participants were families of infants less than 14 days of age presenting to the ED over a 1-year period. The main outcome measure was acuteness of presenting problem. Presenting problems were classified as nonacute if the following 4 criteria were met: (i) no physician referral; (ii) nonurgent triage code assigned by a triage nurse; (iii) no investigations performed in the ED; and (iv) discharge home. Of the 142 eligible infants, 70 (49%) infants presented with nonacute problems. Ninety-two (65%) returned questionnaires. There was no significant difference in the proportion of nonacute problems between infants discharged at less than 48 hours of age and those discharged at more than 48 hours (P = 0.7). The proportion of nonacute problems among infants of primiparous mothers was significantly higher (64%) than among infants of multiparous mothers (24%) (P < 0.001). Infants of mothers less than 25 years of age were more likely to pr...Continue Reading

Associated Clinical Trials

References

Mar 25, 1976·The New England Journal of Medicine·M J YanoverM D Miller
Dec 1, 1990·Clinical Pediatrics·S FeigelmanC DeAngelis
Jun 1, 1985·Pediatric Emergency Care·C DeAngelisA K Duggan
Nov 1, 1995·The Journal of Pediatrics·K S LeeT To
Dec 1, 1994·Annals of Emergency Medicine·E M Brown, V Goel
Aug 1, 1993·American Journal of Diseases of Children·T F OberlanderG E Dougherty
Oct 1, 1995·Current Opinion in Pediatrics·R Dershewitz, R Marshall
Aug 14, 1996·JAMA : the Journal of the American Medical Association·G P YoungD Bouley
Aug 1, 1996·Archives of Pediatrics & Adolescent Medicine·B M Hartley, M E O'Connor
Dec 1, 1996·Pediatric Emergency Care·D S DiekemaL Quan
Jul 23, 1997·JAMA : the Journal of the American Medical Association·L L LiuA H Novack
Oct 6, 1997·Archives of Pediatrics & Adolescent Medicine·K D MandlC J Homer
Jan 22, 1998·Pediatric Emergency Care·A D SacchettiI Bihl
Sep 5, 1998·The Urologic Clinics of North America·J A McCaffreyR J Motzer
Jun 26, 1999·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·V R Nelson
May 3, 2000·Australian and New Zealand Journal of Public Health·S WoolfendenV Nossar
Jul 11, 2000·Pediatric Emergency Care·K R MillarG I Joubert
Jul 11, 2000·Pediatric Emergency Care·E F DonovanU R Kotagal
Sep 29, 2000·Nursing Research·B J PolivkaC Slack

❮ Previous
Next ❯

Citations

Apr 22, 2009·Pediatric Emergency Care·Cláudia Silva CaladoJosé Francisco Maio
Jan 9, 2007·Journal of Paediatrics and Child Health·Setthy UngMelissa Leung
Aug 14, 2012·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·I ClaudetE Grouteau
Nov 20, 2013·Archives of Disease in Childhood·C F Flanagan, M Stewart
Feb 5, 2015·The Journal of Emergency Medicine·Ezgi Deniz BatuOzlem Teksam
Dec 3, 2014·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·P RichierH Patural
Dec 21, 2018·Journal of Paediatrics and Child Health·Faith O AleleKerrianne Watt
Sep 30, 2018·CMAJ Open·JoAnn HarroldUNKNOWN Pediatric Emergency Research Canada Network
Dec 7, 2018·Pediatric Emergency Care·Helena FerreiraIsolina Aguiar
Jul 24, 2018·Soins. Pédiatrie, puériculture·Nina DrozBogdan Cojocaru

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.